Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Classical hematology 1Breast 1

Conditions

Pancreatic Neoplasms 9Peutz-Jeghers Syndrome 3Exocrine Pancreatic Insufficiency 2Pancreatic Intraductal Neoplasms 1Intraductal Papillary Mucinous Neoplasms 1Hereditary pancreatitis 1Hereditary Sensory and Autonomic Neuropathies 1Fanconi Anemia, Complementation Group D1 1Dysplastic Nevus Syndrome 1Diabetes Mellitus 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Breast Neoplasms 1

Interventions

Secretin 3Everolimus 2Sirolimus 1Magnetic Resonance Spectroscopy 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Data Collection 1Celecoxib 1CA-19-9 Antigen 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Peutz-Jeghers Syndrome × Secretin × Clear all
NCT02000089 2025-10-09

CAPS5

Johns Hopkins University

Phase 3 Recruiting
9,000 enrolled
BreastGastrointestinal

Hereditary pancreatitis, Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Dysplastic Nevus Syndrome, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT00438906 2021-06-18

CAPS 3

Johns Hopkins University

Completed
200 enrolled
Classical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT00587132 2013-06-24

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

Mayo Clinic

Phase 1/2 Terminated
4 enrolled 2 charts
Gastrointestinal

Diabetes Mellitus, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡